Delhi NCR-based Rio Health closed a Rs 43.08 crore pre-Series A round this month, led by Version One Ventures with existing backers Xeed Ventures, Good Capital, and Amplify returning. The company, founded by Ankur Agrawal and Amit Ahuja, runs an AI-driven quick-commerce platform for medicines and healthcare essentials, and the money is earmarked for an unglamorous expansion: growing from three dark stores to more than fifteen across the region.
The detail worth more attention than the raise itself is buried in the company’s own usage numbers. Rio Health is processing over 30,000 monthly orders at an average order value of Rs 600 to 700 - and close to 80% of those orders come from repeat customers.
Medicine delivery has a trust problem most categories don’t
Reordering a snack or a phone case is a low-stakes decision. Reordering medicine without re-verifying it is not - it requires a customer to believe the platform got the dosage, the brand, and the expiry right the first time, and will again without being checked. An 80% repeat rate in that category isn’t a loyalty metric in the usual D2C sense. It’s evidence that Rio Health has cleared a trust bar most quick-commerce categories never have to clear at all, where getting it wrong once has consequences a customer actually feels.
The funding is chasing proof, not just an opportunity
Investors backing quick-commerce plays have spent the last few years watching companies buy growth with discounts that evaporate the moment they stop. A high repeat rate funded by actual usage, in a category where trust is hard to fake, is a different kind of signal to underwrite - it suggests the dark-store expansion is scaling something customers already rely on, rather than manufacturing demand that needs the next round just to sustain itself.
What the fifteen-store expansion is actually testing
Three dark stores in a dense market can be run on founder attention and a tight team that personally knows what’s going right. Fifteen is the point where that trust has to survive without anyone watching it closely - consistent stock, correct fulfillment, and the same reliability a customer experienced the first time, repeated at a scale no founder can personally oversee. That’s the real test this round is funding, and it’s a harder one than opening more stores usually sounds like on a term sheet.